← Back to Patent Explorer
US5645824A Expired / Lapsed US ⏱️ 0.0 years remaining

Color changing reagent composition for coating on needles used in medical applications

Assignee: ODLERNO BEN
•
Filing: 1995-10-02
•
Granted: 1997-07-08
•
Expires: 2015-10-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A color changing reagent composition for coating onto syringe needles and other needle containing medical devices which upon contact with such bodily fluids as blood, mucous, saliva, and semen will cause the composition coated needle to change in color to signal a prior use and contamination with a possibly infected bodily fluid. The preferred composition is selected from the group consisting of guaiac acid, benzidine, Barfoeds solution, Benedicts solution, cresol, catechol, phenylenediamine, Haynes solution, phenol, leuco malachite green, leuco-crystal violet, peroxidase, pseudoperoxidase, orthotolodine, orthordianisidine, cumene hydroperoxide, tretramethylbenzedene and 2,2-azinodi-(3-ethylbenzyl)azoline sulfunic acid. After the coated needle comes in contact with a bodily fluid having a catalyst it will, upon oxidation, change from being in a colorless state to having a visually detectable color. The invention will reduce both the mistaken or even intentional re-use of used and possibly disease contaminated needles and provides a revolutionary means of minimizing the continued spread of such bodily fluid transfered diseases as AIDS and Hepatitis B.

Inventors

  • 👤 Min H. Lim
  • 👤 Michael G. Marinangleli

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 07:41
CPC Classifications
A; A61; A61M; A61M5/00; A61M5/178; A61M5/31; A61M5/32; A61M5/50; C; C12; C12Q; C12Q1/00; C12Q1/26; C12Q1/28; A61M2205/00; A61M2205/58; A61M2205/583

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 87 words
A reagent composition for coating onto needles of hypodermic syringes and needle containing medical devices contacting bodily fluids blood, mucous, saliva and semen, comprising: a colorless, reduced leuco dye which upon contact with a bodily fluid containing a hydroperoxide catalyst will, upon oxidation, cause the coated needle to become visually colored, wherein the reduced leuco dye is selected from the group consisting of guaiac acid, Barfoeds solution, Benedicts solution, cresol, cathecol, phenylenediamine, Haynes solution, leuco malachite green, leucocrystal violet, peroxidase, pseudoperoxidase, tetramethylbenzedene and 2,2-azino-di-(3-ethylbenzyl)thiazoline sulfonic acid (ABTS).
Claim 2
Dependent Claim 87 words
A reagent composition for coating onto needles of hypodermic syringes and needle containing medical devices contacting bodily fluids blood, mucous, saliva and semen, comprising: a colorless, reduced leuco dye which upon contact with a bodily fluid containing a hydroperoxide catalyst will, upon oxidation, cause the coated needle to become visually colored, wherein the reduced leuco dye is selected from the group consisting of guaiac acid, Barfoeds solution, Benedicts solution, cresol, cathecol, phenylenediamine, Haynes solution, leuco malachite green, leucocrystal violet, peroxidase, pseudoperoxidase, tetramethylbenzedene and 2,2-azino-di-(3-ethylbenzyl)thiazoline sulfonic acid (ABTS).
Claim 3
Dependent Claim 94 words
A reagent composition for use on needles used in medical applications to test for blood, mucous, saliva, and semen comprising a solution of a hydroperoxide, wherein the hydroperoxide is cumene hydroperoxide, a chromogenic mixture of guaiac acid and 2,2-azino-di-(3-ethylbenzyl)thiazoline sulfonic and sodium sulfite, and a solvent comprising about 50% by volume of iron protoporphyrins, wherein the weight ratio of guaiac to 2,2-azino-di-(3-ethylbenzyl)thiazoline sulfonic acid in the chromogenic mixture is in the range of 1:6 to 6:1, and wherein the chromogen mixture is present in the solution in the range of 0.5 to 10% weight.
Claim 4
Dependent Claim 94 words
A reagent composition for use on needles used in medical applications to test for blood, mucous, saliva, and semen comprising a solution of a hydroperoxide, wherein the hydroperoxide is cumene hydroperoxide, a chromogenic mixture of guaiac acid and 2,2-azino-di-(3-ethylbenzyl)thiazoline sulfonic and sodium sulfite, and a solvent comprising about 50% by volume of iron protoporphyrins, wherein the weight ratio of guaiac to 2,2-azino-di-(3-ethylbenzyl)thiazoline sulfonic acid in the chromogenic mixture is in the range of 1:6 to 6:1, and wherein the chromogen mixture is present in the solution in the range of 0.5 to 10% weight.
Claim 5
Dependent Claim 96 words
A needle for syringes and medical devices that come in contact with disease carrying fluids comprising: a colorless needle which is coated with a reagent composition, wherein the reagent composition is a reduced leuco dye and wherein the reduced leuco dye is selected from the group consisting of guaiac acid, Barfoeds solution, Benedicts solution, cresol, cathecol, benenaphthol, phenylenediamine, Haynes solution, leuco malachite green, leuco-crystal violet, pyrogallol, peroxidase, o-phenylenediamine, 3-amino ethicarbazole, pseudoperoxidase, cumene hydroperoxide, tetramethylbenzedene and 2,2-azino-di-(3-ethylbenzyl)thiazoline sulfonic acid (ABTS) and which upon contact with a bodily fluid catalyst will, when oxidized, assume a visually detectable color.
Claim 6
Dependent Claim 96 words
A needle for syringes and medical devices that come in contact with disease carrying fluids comprising: a colorless needle which is coated with a reagent composition, wherein the reagent composition is a reduced leuco dye and wherein the reduced leuco dye is selected from the group consisting of guaiac acid, Barfoeds solution, Benedicts solution, cresol, cathecol, benenaphthol, phenylenediamine, Haynes solution, leuco malachite green, leuco-crystal violet, pyrogallol, peroxidase, o-phenylenediamine, 3-amino ethicarbazole, pseudoperoxidase, cumene hydroperoxide, tetramethylbenzedene and 2,2-azino-di-(3-ethylbenzyl)thiazoline sulfonic acid (ABTS) and which upon contact with a bodily fluid catalyst will, when oxidized, assume a visually detectable color.

References Cited (Backward Citations)

US3627469A Cited
US4942132A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2000-07-07 2001-01-06 2001-07-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2004-07-07 2005-01-06 2005-07-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2008-07-07 2009-01-06 2009-07-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag